Acrivon Therapeutics, Inc. - COMMON STOCK (ACRV)

Q1 2023 Portfolio Holders as of 3/31/2023

Type / Class
Equity / COMMON STOCK
Number of holders
39
Total Shares
15.2M
Shares change
+535K
Total reported value, excl. options
$191M
Value change
+$6.82M
Put/Call ratio
0
Number of buys
31
Number of sells
-7
Price
$12.69
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.